Atlas Trials

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Etravirine Administered in Combination With Other Antiretroviral Agents in Antiretroviral Treatment-Experienced HIV-1 Infected Patients

Clinical trial NCT01422330 · COMPLETED

Trial details

NCT number
NCT01422330
Sponsor
Janssen R&D Ireland
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Human Immunodeficiency Virus (HIV) Infection
Start date
2011-09-01
Primary completion
2013-11-01
Enrollment
211

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.